Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial.
Möckel M, Searle J, Hartmann O, Anker SD, Peacock WF, Wu AH, Maisel A; BACH Writing group; Slagman A, Vollert JO, Papassotiriou J, Anand I, Christenson R, Daniels LB, Filippatos GS, Hogan C, Morgenthaler N, Mueller C, Neath SX, Ng L, Nowak R, Richards M, Di Somma S, Ponikowski P.
Möckel M, et al. Among authors: wu ah.
Emerg Med J. 2013 Aug;30(8):633-7. doi: 10.1136/emermed-2012-201530. Epub 2012 Sep 9.
Emerg Med J. 2013.
PMID: 22962091
Clinical Trial.